Subcutaneous chronic implantable defibrillation systems in humans-Reference-Cited by-同舟云学术

Subcutaneous chronic implantable defibrillation systems in humans

Published:2012-03-17 Issue:3 Volume:34 Page:325-332
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Cappato Riccardo,Smith Warren M.,Hood Margaret A.,Crozier Ian G.,Jordaens Luc,Spitzer Stefan G.,Ardashev Andrey V.,Boersma Lucas,Lupo Pierpaolo,Grace Andrew A.,Bardy Gust H.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10840-012-9665-6.pdf

Reference39 articles.

1. The AVID Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The New England Journal of Medicine, 337, 1576–1583.

2. Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K. H., Zipes, D. P., Greene, H. L., Boczor, S., Domanski, M., Follmann, D., Gent, M., & Roberts, R. S. (2000). on behalf of the investigators of the AVID, CASH and CIDS studies. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. European Heart Journal, 21, 2071–2078.

3. Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., Brown, M. W., & Heo, M. (1996). for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. The New England Journal of Medicine, 335, 1933–1940.

4. Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002). for the Multicenter Automatic Difibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346, 877–883.

5. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., & Luceri, R. M. (2005). Ip JH for the SCD-HeFT Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352, 225–237.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the Cardiac Patient;Oral and Maxillofacial Surgery for the Medically Compromised Patient;2021-12-07

2. Fracture of an S‐ICD lead after two prior transvenous lead‐related complications with conventional defibrillators;Pacing and Clinical Electrophysiology;2020-10-30

3. Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation;Journal of Interventional Cardiac Electrophysiology;2017-05-23

4. Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy;Circulation: Arrhythmia and Electrophysiology;2017-04

5. Surgical and electrophysiological considerations in the management of a patient with a subcutaneous implantable cardioverter-defibrillator undergoing coronary artery bypass surgery;HeartRhythm Case Reports;2017-01